Mersana Therapeutics, Inc. Long-term Debt, Gross
Mersana Therapeutics, Inc. had Long-term Debt, Gross of $16.70 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2025-08-13
- 2025-06-30: Long-term Debt, Gross $16.70M.
- 2025-03-31: Long-term Debt, Gross $19.79M.
- 2024-12-31: Long-term Debt, Gross $22.92M.
- 2024-09-30: Long-term Debt, Gross $25.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2025-06-30 | $16.70M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $19.79M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $22.92M 10-K · filed 2025-03-03 |
| 2024-09-30 | $25.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $25.00M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $25.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $25.00M 10-K · filed 2024-02-28 |
| 2023-09-30 | $25.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $25.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $25.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $25.00M 10-K · filed 2023-02-28 |
| 2022-09-30 | $25.00M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $25.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $25.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $25.00M 10-K · filed 2022-02-28 |
| 2021-09-30 | $5.20M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.20M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $5.20M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.20M 10-K · filed 2021-02-26 |
| 2020-09-30 | $5.20M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $5.00M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $5.00M 10-K · filed 2020-02-28 |
| 2019-09-30 | $5.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $5.00M 10-Q · filed 2019-08-08 |